Denali Therapeutics and Biogen Announce Initiation of Phase 2b Study of LRRK2 Inhibitor in Parkinson’s Disease May 31, 2022
Apotea Deploys RightPick™ 3 Item-Handling System from RightHand Robotics™ to Expedite Operations for Consumers May 26, 2022
Insilico Medicine Announces Novel 3CL Protease Inhibitor Preclinical Candidate for COVID-19 Treatment May 24, 2022